Yukio Nagasaki

Researcher Name Resolver ID ORCID

Publication Activity (10 Years)

Years Active: 2017-2024
Publications (10 Years): 18

Top Topics

Reactive Oxygen Species

Anti Inflammatory

Top Venues

ACS biomaterials science & engineering

Journal of biomedical materials research. Part A

Science and technology of advanced materials

This page only lists publications with an associated author ORCID identifier.

Publications

Duc Tri Bui, Yukio Nagasaki
Developing poly(ethylene glycol)- b -poly(β-hydroxybutyrate)-based self-assembling prodrug for the management of cisplatin-induced acute kidney injury. Science and technology of advanced materials 25 (1) (2024)
Wiwit Suttithumsatid, Takuto Toriumi, Wanida Sukketsiri, Yukio Nagasaki, Pharkphoom Panichayupakaranant
Enhanced Stability of α-Mangostin-Rich Extract and Selective Cytotoxicity against Cancer Cells via Encapsulation in Antioxidant Nanoparticles (AME@Nano AOX ). ACS biomaterials science & engineering (2024)
Duc Tri Bui, Yukio Nagasaki
Developing poly(ethylene glycol)- b -poly(β-hydroxybutyrate)-based self-assembling prodrug for the management of cisplatin-induced acute kidney injury. Science and technology of advanced materials 25 (1) (2024)
Wiwit Suttithumsatid, Takuto Toriumi, Wanida Sukketsiri, Yukio Nagasaki, Pharkphoom Panichayupakaranant
Enhanced Stability of α-Mangostin-Rich Extract and Selective Cytotoxicity against Cancer Cells via Encapsulation in Antioxidant Nanoparticles (AME@Nano AOX ). ACS biomaterials science & engineering 10 (8) (2024)
Takuto Toriumi, Hajime Ohmori, Yukio Nagasaki
Design of Antioxidant Nanoparticle, which Selectively Locates and Scavenges Reactive Oxygen Species in the Gastrointestinal Tract, Increasing The Running Time of Mice. Advanced science (Weinheim, Baden-Wurttemberg, Germany) (2023)
Yuta Koda, Yukio Nagasaki
Newly Designed Cysteine-Based Self-Assembling Prodrugs for Sepsis Treatment. Pharmaceutics 15 (6) (2023)
Yuta Koda, Yukio Nagasaki
Newly Designed Cysteine-Based Self-Assembling Prodrugs for Sepsis Treatment. Pharmaceutics 15 (6) (2023)
Yutaka Ikeda, Yuya Tajika, Yukio Nagasaki
Design of self-assembling anti-epileptic drug for long-acting drug delivery in vivo . Biomaterials science 10 (21) (2022)
Toru Yoshitomi, Yukio Nagasaki
Self-Assembling Antioxidants for Ischemia-Reperfusion Injuries. Antioxidants & redox signaling (2021)
Ahram Kim, Chiaki Yonemoto, Chitho P Feliciano, Babita Shashni, Yukio Nagasaki
Antioxidant Nanomedicine Significantly Enhances the Survival Benefit of Radiation Cancer Therapy by Mitigating Oxidative Stress-Induced Side Effects. Small (Weinheim an der Bergstrasse, Germany) 17 (21) (2021)
Takuto Toriumi, Ahram Kim, Shoichi Komine, Ikuru Miura, Suminori Nagayama, Hajime Ohmori, Yukio Nagasaki
An Antioxidant Nanoparticle Enhances Exercise Performance in Rat High-intensity Running Models. Advanced healthcare materials 10 (10) (2021)
Babita Shashni, Yukio Nagasaki
Newly Developed Self-Assembling Antioxidants as Potential Therapeutics for the Cancers. Journal of personalized medicine 11 (2) (2021)
Yutaka Ikeda, Naoki Inuzuka, Mitsuaki Goto, Toshihiro Akaike, Yukio Nagasaki
An anti-oxidative cell culture dish inhibits intracellular reactive oxygen species accumulation and modulates pluripotency-associated gene expression in mesenchymal stem cells. Journal of biomedical materials research. Part A 108 (5) (2020)
Long Binh Vong, Yukio Nagasaki
Nitric Oxide Nano-Delivery Systems for Cancer Therapeutics: Advances and Challenges. Antioxidants (Basel, Switzerland) 9 (9) (2020)
Shiro Ishii, Sho Sakaue, Yukio Nagasaki
Redox-active injectable gel using polyion complex to achieve sustained release of exenatide and enhance therapeutic efficacy for the treatment of type 2 diabetes. Journal of biomedical materials research. Part A 107 (5) (2019)
Chitho P Feliciano, Yukio Nagasaki
Antioxidant Nanomedicine Protects against Ionizing Radiation-Induced Life-Shortening in C57BL/6J Mice. ACS biomaterials science & engineering 5 (11) (2019)
Yutaka Ikeda, Kazuhiro Shoji, Chitho P Feliciano, Shinji Saito, Yukio Nagasaki
Antioxidative Nanoparticles Significantly Enhance Therapeutic Efficacy of an Antibacterial Therapy against Listeria monocytogenes Infection. Molecular pharmaceutics 15 (3) (2018)
Long Binh Vong, Shinya Kimura, Yukio Nagasaki
Newly Designed Silica-Containing Redox Nanoparticles for Oral Delivery of Novel TOP2 Catalytic Inhibitor for Treating Colon Cancer. Advanced healthcare materials 6 (20) (2017)